Saliva versus peri-implant inflammation: Quantification of il-1β in partially and totally edentulous patients

Journal of Oral Implantology

Volumn 40, Issue 2, 2014, Pages 169-173

  Rocha, Flaviana Soares ^a   Jesus, Rainde Naiara Rezende ^a   Rocha, Fabiana Maria Soares ^a   Moura, Camilla Cristhian Gomes ^a   Zanetta Barbosa, Darceny ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Cytokines; Dental implant; Inflammation; Peri implant sulcular fluid

Indexed keywords

INTERLEUKIN 1BETA; SALIVA PROTEIN;

ARTICLE; BONE REGENERATION; CLASSIFICATION; COMPARATIVE STUDY; EDENTULOUSNESS; FEMALE; GINGIVA BLEEDING; HUMAN; IMMUNOLOGY; MALE; MOUTH DISEASE; PERIODONTAL DISEASE; PERIODONTAL POCKET; PHYSIOLOGY; SALIVA; STOMATITIS; SUPPURATION; TOOTH IMPLANT; TOOTH PLAQUE;

DENTAL IMPLANTS; DENTAL PLAQUE INDEX; FEMALE; GINGIVAL HEMORRHAGE; HUMANS; INTERLEUKIN-1BETA; JAW, EDENTULOUS, PARTIALLY; MALE; MOUTH, EDENTULOUS; OSSEOINTEGRATION; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; SALIVA; SALIVARY PROTEINS AND PEPTIDES; STOMATITIS; SUPPURATION;

EID: 84901828986     PISSN: 01606972     EISSN: 15481336     Source Type: Journal    
DOI: 10.1563/AAID-JOI-D-11-00224     Document Type: Article

References (19)

1. Lang NP, Berglundh T, Heitz-Mayfield LJ, Pjetursson BE, Salvi GE, Sanz M. Consensus statements and recommended clinical procedures regarding implant survival and complications. Int J Oral Maxillofac Implants. 2004;19 Suppl:150-154.
2. Qrirynen M, Alsaadi G, Pauwels M, Haffajee A, van Steenberghe D, Naert I. Microbiological and clinical outcomes and patient satisfaction for two treatment options in the edentulous lower jaw after 10 years of function. Clin. Oral Impl Res. 2005; 16:277-287.
3. Degidi M, Artese L, Scarano A, Perrotti V, Gehrke P, Piattelli A. Inflammatory infiltrate, microvessel density, nitric oxide synthase expression, vascular endothelial growth factor expression, and proliferative activity in peri-implant soft tissues around titanium and zirconium oxide healing caps. J Periodontol. 2006;77:73-80.
4. Heitz-Mayfield LJ. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol. 2008;35:292-304. Review.
5. Tözüm TF, Turkyilmaz I, Yamalik N, Karabulut E, Türkyilmaz AS, Eratalay K. Analysis of the possibility of the relationship between various implant-related measures: an 18-month follow-up study. J Oral Rehabil. 2008;35:95-104.
6. Lee A, Ghaname CB, Braun TM, et al. Bacterial and salivary biomarkers predict the gingival inflammatory profile. J Periodontol. 2012;83:79-89.
7. Liskmann S, Vihalemm T, Salum O, Zilmer K, Fischer K, Zilmer M. Characterization of the antioxidant profile of human saliva in peri-implant health and disease. Clin Oral Impl Res. 2007;18: 27-33.
8. Sexton WM, Lin Y, Kryscio RJ, Dawson DR 3rd, Ebersole JL, Miller CS. Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol. 2011;38:434-441.
9. Ng PYB, Donley M, Hausmann E, Hutson AD, Rossomando EF, Scannapiecco FA. Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol. 2007;49:252-260.
10. Tobón-Arroyave SI, Jaramillo-Gonzalez, Isaza-Guzman DM. Correlation between salivary IL-1b levels and periodontal clinical status. Arch Oral Biol. 2008;53:346-352.
11. Schierano G, Pejrone G, Brusco P, et al. TNF-alpha TGFbeta2 and IL-1beta levels in gingival and peri-implant crevicular fluid before and after de novo plaque accumulation. J Clin Periodontol. 2008;35:532-538.
12. Mombelli A, van Oosten MA, Schurch E Jr, Land NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987;2:145-151.
13. Bonachela WC, Rossetti PHO. Das raízes aos implantes osseointegrados: planejamentos, tendências e inovaç~oes [in Spanish]. São Paulo, Brazil: Santos; 2002.
14. Renvert S, Roos-Jansåker AM, Lindahl C, Renvert H, Rutger Persson G. Infection at titanium implants with or without a clinical diagnosis of inflammation. Clin Oral Implants Res. 2007;18:509-516.
15. Ataoglu H, Alptekin NO, Haliloglu S, et al. Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res. 2002;13:470-476.
16. Murata M, Tatsumi J, Kato Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res. 2002;13:637-643.
17. Nowzari H, Botero JE, DeGiacomo M, Villacres MC, Rich SK. Microbiology and cytokine levels around healthy dental implants and teeth. Clin Implant Dent Relat Res. 2008;10:166-173.
18. Schultze-Mosgau S, Wehrhan F, Wichmann M, Schlegel KA, Holst S, Thorwarth M. Expression of interleukin 1-beta, transforming growth factor beta-1, and vascular endothelial growth factor in soft tissue over the implant before uncovering. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:565-571.
19. Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL1β profiles in periodontal disease. J Clin Periodontol. 2002;29:48-53.